Phase 2 RCT | Effects of Difelikefalin in notalgia paresthetica

Phase 2 Trial of Difelikefalin in Notalgia Paresthetica – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

Phase 2 Trial Finds Difelikefalin Could Prove Useful in Notalgia Paresthetica – HCP Live

Difelikefalin Improves Itch Intensity in Notalgia Paresthetica – HealthDay

Commentary on Twitter

In a phase 2 trial in notalgia paresthetica, oral difelikefalin treatment resulted in modestly reduced itch as compared with placebo. https://t.co/MQMO7z4o0W pic.twitter.com/2iaCgb3c93

— NEJM (@NEJM) February 8, 2023